Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Christopher J CorcoranDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0000-0001-8796-2883
David G GlanvilleDivision of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-8487-5941
Zachary J ReskoDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0000-0003-4421-5145
Erin K CassinSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
Andrew D MartenDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.
Derrick L KampDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, USA.ORCID 0000-0003-1787-1825
Karen L VisickDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0000-0002-2400-2591
Spencer V NyholmDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, USA.ORCID 0000-0001-5597-1945
Boo Shan TsengSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.ORCID 0000-0001-7563-0232
Abby R KrokenDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0000-0003-1807-1125
Andrew T UlijaszDivision of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0003-0739-1297
Funding
Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Eduardo A Robleto · 2012 to 2026
$58.0M
Childhood Infections Research ProgramT32AI095202 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JAMES E CASSAT · 2011 to 2026
$4.2M
Host-associated biofilm formation and dispersal mechanismsR35GM130355 · NIGMS · LOYOLA UNIVERSITY CHICAGO · PI Karen L Visick · 2019 to 2026
$3.5M
A Regulatory Cascade that Controls Pneumococcal Capsule BiosynthesisR01AI135060 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI ULIJASZ, ANDREW T · 2019 to 2023
$2.3M
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteriaR01EY034239 · NEI · LOYOLA UNIVERSITY CHICAGO · PI Abby R Kroken · 2022 to 2026
$1.9M
A novel family of conserved glyoxal toxicity response proteins.R01GM141230 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ULIJASZ, ANDREW T · 2022 to 2025
$1.7M
Exploring envelope stress response toxicity and regulation in gram-negative bacteriaR16GM149513 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI Boo Shan Tseng · 2023 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A versatile dual-color bacterial reporter system highlights two distinct · full record | OpenQuestion